KDR and neoplasm: PDT and VEGF/VEGFR double inhibitor (Avastin + Erbitux) lead to an obvious decrease in VEGF and EGFR and considerable tumor elimination in a murine bladder tumor model (Bhuvaneswari et al., 2011).